Diabetes

FDA Approves New Drug to Treat Type I and Type II Diabetes

The Food and Drug Administration (FDA) today approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone. Symlin will be the only therapy for the treatment of type 1 diabetes other than in...

Chemists identify key gene in development of type 1 diabetes

Chemists say they have identified a gene that appears to play a key role in the development of type 1 diabetes, also known as insulin-dependent or juvenile diabetes, a disease that affects about one million people in the U.S. and is on the rise worldwide. They described their findings, which they say could lead to new drug interventions and possibly gene therapy, today at the 229th national meeti...

Rare surgery performed to remove pancreas, prevent diabetes

In a 12-hour, dual-stage surgery known to be performed at only two other centers in the U.S., doctors at the University of Alabama at Birmingham on Tuesday returned a patient's own insulin-producing cells to him after surgically removing his pancreas to eliminate constant, severe pain from chronic pancreatitis. The patient, Leonard Stewart, 47, of Panama City, Fla., remained anesthetized i...

First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes

Biologists at the University of Liverpool have discovered how the plagues of the Middle Ages have made around 10% of Europeans resistant to HIV. Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-delta32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavi...

Future diabetes drugs may target new protein interaction

In the March 3 issue of Nature, Johns Hopkins researchers report that two proteins best known for very different activities actually come together to turn the liver into a sugar-producing factory when food is scarce. Because the liver's production of sugar is a damaging problem in people with diabetes, the proteins' interaction might be a target for future drugs to fight the disease, the research...

More>>

Diabetes at Biology Products

No data found

Search Diabetes biology products at Google

Search Diabetes biology products at Yahoo

Search Diabetes biology products at Msn

Diabetes at Biology Technology

Embryonic stem cells advance diabetes cure

<...

Diabetes at Biology Definition

Diabetes mellitus

and complications at advanced st...

Diabetes at Medicine News

Is Diabetes the Leading Cause of Kidney Failure in India

No one knows the answer to this one as we do not have collective data, however diabetes is the number one cause of kidney failure in the United States, accounting for more than 40 percent of the new cases of end-stage renal disease (ESRD)each year. People with ESRD require regular dialysis or a kidney transplant to stay alive. Almost 25% of patients suffering from diabetes will get kidney problem...

Diabetes and Depression often go hand-in-hand

An analysis of 25 years of data has revealed that diabetes and depression go hand in hand for many people. People with Diabetes are twice as likely as non-diabetics to suffer from depression, researchers say. The June issue of Diabetes Care carries the report of this study. Dr. Patrick Lustman of Washington University School of Medicine and the Department of Veterans Affairs Medical Center in St....

Vitamin E, the latest warrior against diabetes

Scientists are assessing research that suggests high doses of vitamin E may help fight diabetes. Diabetes is one of the most prevalent diseases in the world with many ravaging complications, affecting millions of people. Complications can lead to heart disease, eye damage, kidney failure, non healing ulcers all over the body and can also cause complications of the nervous system. Diabet...

Thirty minutes of work up per day reduces the risk of Diabetes

Diabetes Prevention Program, sponsored by the National Institutes of Health, showed that at-risk people who exercised at least 30 minutes per day reduced their risk of diabetes by 58%, even without medication. People who are at risk of developing type 2 diabetes can sharply reduce the odds through a regular regimen of diet and exercise, according to data from the nation's first major c...

Diabetes on the rise

The world's largest diabetes epidemic is threatening India, which is ill-equipped to cope, say experts. The amount of type II, or adult-onset diabetes in Indian cities is high, and rising, suggests health data. India has a population of more than a billion, and its citizens appear prone to developing diabetes later in life, and are certainly more vulnerable to its complications such as high b...

More>>

Diabetes at Medicine Products

Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01

Description:Insulin is the principal hormone responsible for the control of glucose metabolism. It is synthesized in the b-cells of the islets of Langerhans as the precursor, proinsulin, which is processed to form C-peptide and insulin. Both are secreted in equimolar amounts into the portal circulation. The mature insulin molecule is comprised of two polypeptide chains, the A-chain and B-chain (21 and 30...
Company:ALPCO Diagnostics

Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01

Description:Insulin is the principal hormone responsible for the control of glucose metabolism. It is synthesized in the b-cells of the islets of Langerhans as the precursor, proinsulin, which is processed to form C-peptide and insulin. Both are secreted in equimolar amounts into the portal circulation. The mature insulin molecule is comprised of two polypeptide chains, the A-chain and B-chain (21 and 30...
Company:ALPCO Diagnostics

Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01

Description:Qualitative and quantitative evaluation of pancreatic -cell function is not only of use in the pre- and post-diagnostic study of the natural history of diabetes mellitus, but is also relevant in clinical practice as a guide to the correct choice of treatment. Peripheral insulin levels cannot be used to assess -cell function because of the large and variable uptake from the portal circulation into...
Company:ALPCO Diagnostics

Insulin EIA Diabetes and Obesity Markers 008-10-1113-01

Description:Insulin is the principal hormone responsible for the control of glucose metabolism. It is synthesized in the b-cells of the islets of Langerhans as the precursor, proinsulin, which is processed to form C-peptide and insulin. Both are secreted in equimolar amounts into the portal circulation. The mature insulin molecule is comprised of two polypeptide chains, the A-chain and B-chain (21 and 30...
Company:ALPCO Diagnostics

C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01

Description:Qualitative and quantitative evaluation of pancreatic b-cell function is not only of use in the pre- and post-diagnostic study of the natural history of diabetes mellitus, but is also relevant in clinical practice as a guide to the correct choice of treatment. Peripheral insulin levels cannot be used to assess b-cell function because of the large and variable uptake from the portal circulation...
Company:ALPCO Diagnostics

More>>

Diabetes at Medicine Technology

Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control

According to the American Diabetes Association, the total annual economic cost of diabetes in 2002 was estimated to be $132 billion, or one out of every 10 health care dollars spent in the United States. A chronic disease with no cure, diabetes is a group of diseases (including Type 1, Type 2, and gestational) marked by...

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients

Final Results from Exploratory Phase IIa Clinical Trial in Type 2Diabetes Patients Announced TORONTO, June 28, 2007 /PRNewswire-FirstCall/ - TransitionTherapeutics Inc. ("Transition") , today announces the results fromits exploratory Phase IIa clinical trial indicating that 4-weeks ofdaily treatments with gastrin-based therapy, E1-I.N.T.(TM), showedsustained reductions in blood glucose co...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

-- Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects -- CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company and A...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company (NYSE: BMY...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - New data from aninvestigational study released at the American Diabetes Association(ADA) 67th Annual Scientific Sessions showed that initialcombination therapy with Januvia(TM) (sitagliptin) and metformindemonstrated significant improvement in markers of beta cellfunction in patients with type 2 diabetes. Pancreatic islet betacell function determines...

More>>

Diabetes at Medicine Dictionary

Type II diabetes

and may be delayed or controlled with <a href="/ ?q=/ Medicine-Dicti...

Type I diabetes

secrete the <a href="/ ?q=/ Medicine-Dictiona...

Type 2 diabetes

<A...

Sugar diabetes

<A href="http:/ / www.mayoclinic.com/ health/ drug-informat...

Noninsulin-dependent diabetes mellitus

Alternate Names Diabetes</ ...

More>>